Article ID Journal Published Year Pages File Type
3328520 Critical Reviews in Oncology/Hematology 2016 10 Pages PDF
Abstract

Even though the pathogenesis of myelodysplastic syndromes (MDS) is dominated by specific molecular defects involving hematopoietic precursors, also immune mechanisms seem to play a fundamental functional role. In this review we will first describe the clinical and laboratory autoimmune manifestations often detectable in MDS patients. We will then focus on studies addressing the possible influence of different immune cell subpopulations on the disease onset and evolution. We will finally consider therapeutic approaches based on immunomodulation, ranging from immunosuppressants to vaccination and transplantation strategies.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, , , ,